Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
CXCR4-directed RLT exerted relevant myeloablative effects. When performing HSCT after applying additional CON, successful neutrophile engraftment was reached in the vast majority of the cases.
Authors
- Hermann Einsele (ORCID: https://orcid.org/0000-0002-7680-0819)
- Andreas K. Buck (ORCID: https://orcid.org/0000-0002-6447-0613)
- Sebastian E. Serfling (ORCID: https://orcid.org/0009-0001-5740-0537)
- Leo Rasche (ORCID: https://orcid.org/0000-0002-9536-9649)
- Rudolf Alexander Werner (ORCID: https://orcid.org/0000-0003-3372-6046)
- Samuel Samnick
- Niklas Dreher (ORCID: https://orcid.org/0000-0003-2921-8452)
- Takahiro Higuchi (ORCID: https://orcid.org/0000-0001-9711-7835)
- Sabrina Kraus (ORCID: https://orcid.org/0000-0001-8954-4220)
- Anna-Lena Dörrler
- Constantin Lapa (ORCID: https://orcid.org/0000-0001-7536-2207)
Institutions
- Johns Hopkins University (US)
- University of Augsburg (DE)
- LMU Klinikum (DE)
- Universitätsklinikum Würzburg (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1097/rlu.0000000000005813
- Citations
- 6
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 10.62
Funders
- Deutsche Forschungsgemeinschaft